Tuesday, November 17, 2009

Mesothelioma

Mesothelioma is a rare cancer that can develop in the membrane that lines the lungs, called the mesothelium. It causes shortness of breath, severe cough, and chest pain. Mesothelioma is often diagnosed in later stages of development, which severely complicates treatment and chances of survival. There are thousands of cases of Mesothelioma diagnosed each year in the U.S., comprising around 3 percent of all cancer diagnoses. It is 4 times as common among men.

The disease derives its name from the mesothelium, a sac-like membrane that protects most of the body's internal organs. It is divided into two distinct protective layers of cells: the visceral (the layer directly surrounding the organ) and the parietal (a sac around the body cavity). By releasing a lubricating fluid, the mesothelium allows the organs to move more freely within the body cavity; for example, the contraction and expansion of the lungs. The mesothelium is also referred to according to where it is located in the body: pleura (chest), peritoneum (abdomen), and pericardium (heart).

Like most cancers, the prognosis for this disease often depends on how early it is diagnosed and how aggressively it is treated. Treatment options range from surgery to chemotherapy to radiation therapy to experimental treatments. Most chemotherapy drugs have specific side effects such as nausea, vomiting, loss of appetite, hair loss, and increased vulnerability to infection. Symptoms experienced while undergoing treatment with chemotherapeutic drugs are usually reported to the doctor, but why go through all that?

LifeMel Honey is unique. It is an innovative groundbreaking product for the support of patients suffering from the side effects of chemotherapy and radiation treatment. What makes it innovative? The bees are fed on a special nectar derived from therapeutic herbs including Siberian Ginseng, Echinacea and Uncaria Tomentosa, combined with a selection of natural ingredients. Learn more by visiting LifeMelUSA.com

No comments:

Post a Comment